E70.2 类别:需要更具体的编码 Disorders of tyrosine metabolism

ICD-10-CM E70.2 identifies “Disorders of tyrosine metabolism” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

章节 4: Endocrine, nutritional and metabolic diseases

编码说明

Excludes 11

transitory tyrosinemia of newborn (P74.5)

上级编码说明

章节 4 · Endocrine, nutritional and metabolic diseases (E00-E89)

Excludes 11

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note1

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

E70-E88 · Metabolic disorders (E70-E88)

Excludes 15
  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan syndrome (Q87.4-)
  • 5-alpha-reductase deficiency (E29.1)
Excludes 21

Ehlers-Danlos syndromes (Q79.6-)

更具体的编码

官方索引引用
历史

编码历史

最近记录的变更 · FY2024

已变更无变更
FY2024

生效日期

  • 上级说明变更

Disorders of tyrosine metabolism

类别 — 请选择更具体的编码

CDC/NCHS · FY2024

所有版本 (19)

所有版本生效日期编码历史
FY20162015-10-01首次收录
FY20172016-10-01分类表无变更
FY20182017-10-01分类表无变更
FY20192018-10-01分类表无变更
FY20202019-10-01上级说明变更
FY2020 · April2020-04-01分类表无变更
FY20212020-10-01上级说明变更
FY2021 · 01-012021-01-01分类表无变更
FY20222021-10-01上级说明变更
FY2022 · 04-012022-04-01分类表无变更
FY20232022-10-01分类表无变更
FY2023 · 04-012023-04-01分类表无变更
FY20242023-10-01上级说明变更
FY2024 · 04-012024-04-01分类表无变更
FY20252024-10-01分类表无变更
FY2025 · 04-012025-04-01分类表无变更
FY20262025-10-01分类表无变更
FY2026 · April2026-04-01分类表无变更
FY20272026-10-01分类表无变更

浏览此类别中更具体的编码。 参考核验不能确定临床适用性,也不保证报销。